Provided by Tiger Trade Technology Pte. Ltd.

IDEXX Laboratories

554.99
+9.911.82%
Post-market: 554.990.00000.00%19:30 EDT
Volume:340.99K
Turnover:188.65M
Market Cap:43.78B
PE:39.00
High:556.01
Open:547.81
Low:545.48
Close:545.08
52wk High:769.98
52wk Low:518.55
Shares:78.88M
Float Shares:78.57M
Volume Ratio:0.87
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.23
EPS(LYR):13.08
ROE:74.21%
ROA:27.08%
PB:27.15
PE(LYR):42.43

Loading ...

Idexx Q2 EPS Usd 4.27

Reuters
·
Aug 04

IDEXX Laboratories Q2 EPS $4.27 Beats $3.96 Estimate, Sales $1.217B Beat $1.201B Estimate

Benzinga Earnings
·
Aug 04

IDEXX Q2 EBIT Margin 35%

THOMSON REUTERS
·
Aug 04

IDEXX Outlook FY EPS USD 14.69-14.94

THOMSON REUTERS
·
Aug 04

IDEXX Laboratories Outlook FY Reported Operating Margin 32.3% - 32.5%

THOMSON REUTERS
·
Aug 04

IDEXX Laboratories Inc Fy2026 Shr View $14.65, REV View $4.71 Bln

THOMSON REUTERS
·
Aug 04

IDEXX Laboratories Announces Second Quarter Results

THOMSON REUTERS
·
Aug 04

Stock Track | IDEXX Laboratories Soars 5.31% in Pre-Market on Q2 Earnings Release Anticipation

Stock Track
·
Aug 04

Movement Alert|IDEXX Laboratories Rises 5.29% in Pre-Market Trading, Q2 Earnings Release Sparks Positive Market Reaction

Market Focus
·
Aug 04

IDEXX Laboratories Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 04

Top News Today/Canada: WestJet Strike Grounds Hundreds of Flights in Canada

Dow Jones
·
Aug 04

Zoetis Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 31

IDEXX Laboratories Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 31

Earning Preview: IDEXX Laboratories’ revenue is expected to increase by 12.49%, and institutional views are leaning bullish

Earnings Agent
·
Jul 29

IDEXX Releases 2025 Corporate Responsibility Report

Reuters
·
Jul 28

Revvity Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

IDEXX Laboratories Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 28

IDEXX Labs is Maintained at Neutral by UBS

Dow Jones
·
Jul 28

Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says

MT Newswires Live
·
Jul 28

UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating

MT Newswires Live
·
Jul 27